Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Oncofertility
  • Reduced price
Fundamentals of HIV Medicine 2021

Fundamentals of HIV Medicine 2021

9780197576595
575.64 zł
518.08 zł Save 57.56 zł Tax included
Lowest price within 30 days before promotion: 518.08 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
The essential work in HIV for providers and pharmacists-updated with everything they need to know in 2021!An end-to-end clinical resource for the treatment of individuals with HIV/AIDS, Fundamentals of HIV Medicine has served as a key resource for clinicians preventing and treating HIV for over a decade. Now updated for 2021, Fundamentals of HIV Medicine 2021 offers state-of-the-art continuing education for physicians, pharmacists, nurse practitioners, nurses, and other professionals working in the care of HIV patients.With this volume, practitioners will have immediate, indexed access to the most updated science, research, and guidelines related to all aspects of HIV care and prevention. This revised edition features key clinical updates across classic domains of HIV medicine along with recent research in HIV medicine including HIV workforce strains and PrEP, newly emerging antiretroviral treatment options, and the evolving effects of COVID-19 on HIV care.Embodying the American Academy of HIV Medicines commitment to excellence in the care of seropositive patients, Fundamentals of HIV Medicine 2021 is a must-have for health professionals across HIV care, treatment, and prevention.
Product Details
OUP USA
90836
9780197576595
9780197576595

Data sheet

Publication date
2021
Issue number
1
Cover
paperback
Pages count
552
Dimensions (mm)
216 x 279
Weight (g)
1338
  • Target Audience; Overall Learning Objectives; Editors and Contributors; Contributor Disclosures; Disclosure of Unlabeled Use; 1. Ending of the HIV Epidemic: A Plan for American Initiatives in the United States; 2. Epidemiology and the Spread of HIV; 3. The Origin, Evolution, and Epidemiology of HIV-1 and HIV-2; 4. Mechanisms of HIV Transmission; 5. HIV Transmission Prevention; 6. Immunology; 7. HIV Testing and Counseling; 8. Laboratory Testing Strategies, Detection, and Diagnosis; 9. Initial Evaluation of the Person Living with HIV: History, Physical Examination, and Laboratory Evaluation; 10. Health Maintenance; 11. Diversity and Health Disparities; 12. Complementary and Alternative Medicine/Integrative Medicine Approaches; 13. HIV Care Coordination; 14. The Pharmacists Role in HIV Care; 15. Palliative Care and End of Life Support; 16. Virology and Natural History of HIV; 17. Scientific Basis of Antiretroviral Therapy; 18. Prescribing Antiretroviral Therapy; 19. The HIV Reservoir and Cure and Remission Strategies; 20. Antiretroviral Resistance: Evaluation and Clinical Management; 21. Antiretrovirals During and After Hospitalization, Including Bariatric Surgery; 22. Solid Organ Transplantation in Persons with HIV; 23. Select Topics in the Care of Women with HIV; 24. Antiretroviral Therapy for Children and Newborns; 25. Understanding and Managing Antineoplastic and Antiretroviral Therapy; 26. Substance Use in HIV Populations; 27. Caring for Older People with HIV; 28. Opportunistic Infections; 29. Malignancies in HIV; 30. Dermatologic Complications of HIV; 31. Endocrine and Metabolic Disorders; 32. Non-opportunistic Infections: Respiratory Complications; 33. Psychiatric Illness and Treatment in HIV Populations; 34. Neurological Effects of HIV Infection; 35. HIV and Hepatitis Coinfection; 36. The COVID-19 Pandemic and HIV; 37. Sexually Transmitted Diseases; 38. Cardiovascular Disease; 39. Renal Complications; 40. HIV and Bone Health; 41. HIV-associated Lipodystrophy and Lipoatrophy; 42. Immune Reconstitution Inflammatory Syndrome (IRIS); 43. U.S. Healthcare Systems, HIV Programs, and Coverage Policy Issues; 44. Legal Issues; 45. Research Design and Analysis; 46. Ethical Conduct of Clinical Trials, Institutional Review Boards, Informed Consent, and Financial Conflicts of Interest; Index;
Comments (0)

  • Frequently purchased together

    No products available